PREIMPLANTATION GENETIC TESTING FOR SICKLE CELL DISEASE – A COST EFFECTIVENESS ANALYSIS (IN PRESS)

Joshua Combs, Maura Dougherty, Meghan Yamasaki, Alan DeCherney, Kate Devine, Micah Hill, Erin Rothwell, Jeanne O’Brien, Richard Nelson. F&S Reports. doi:https://doi.org/10.1016/j.xfre.2023.06.001 

Previous
Previous

NEUROKININ RECEPTOR ANTAGONISTS AS POTENTIAL NON-HORMONAL TREATMENTS FOR VASOMOTOR SYMPTOMS OF MENOPAUSE

Next
Next

FETAL GROWTH VELOCITY ACCORDING TO THE MODE OF ASSISTED CONCEPTION